Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
Condition(s) studied
Investigational drug(s) / intervention(s)
Radical surgery with PALND: sufficient resection margins of the tumor, D3 dissection of the regional lymph nodes and para-aortic lymph node dissection from the bifurcation of iliac artery to the left renal vein via laparoscopic approach
Radical surgery without PALND: surgery includes sufficient resection margins of the tumor and D3 dissection of the regional lymph nodes without PALND
Study summary
In left-sided colon and rectal cancer, the occurrence of synchronous para-aortic lymph node metastasis is rare, with the incidence of being approximate 1-2%. Currently, there has been no standard treatment strategy for this situation. The present trial is designed to evaluate the safety and efficacy of para-aortic lymph node dissection for left-sided colon and rectal cancer with synchronous para-aortic lymph node metastasis
Eligibility
Primary outcome measure(s)
- 5-year OS — From date of recruitment until the date of death from any cause, assessed up to 5 years
5-year overall survival
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Qilu Hospital of Shandong University | Jinan | Shandong |
More Qilu Hospital of Shandong University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05129774 on ClinicalTrials.gov ↗ ← All trials in China